The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Altered PPARγ expression and activation after transient focal ischemia in rats
Abstract
Stroke is a devastating disease with limited treatment options. Recently, we found that the peroxisome proliferator‐activated receptor‐γ (PPARγ) agonists troglitazone and pioglitazone reduce injury and inflammation in a rat model of transient cerebral ischemia. The mechanism of this protection is unclear, as these agents can act through PPAR‐γ activation or through PPAR‐γ‐independent mechanisms. Therefore, we examined PPAR‐γ expression, DNA binding and transcriptional activity following stroke. In addition, we used a PPAR‐γ antagonist, T0070907, to determine the role of PPAR‐γ during ischemia. Using immunohistochemical techniques and real‐time PCR, we found low levels of PPAR‐γ mRNA and PPAR‐γ immunoreactivity in nonischemic brain; however, PPAR‐γ expression dramatically increased in ischemic neurons, peaking 24 h following middle cerebral artery occlusion. Interestingly, we found that in both vehicle‐ and agonist‐treated brains, DNA binding was reduced in the ischemic hemisphere relative to the contralateral hemisphere. Expression of a PPAR‐γ target gene, lipoprotein lipase, was also reduced in ischemic relative to nonischemic brain. Both DNA binding and lipoprotein lipase expression were increased by the addition of the PPAR‐γ agonist rosiglitazone. Finally, we found that rosiglitazone‐mediated protection after stroke was reversed by the PPAR‐γ antagonist T0070907. Interestingly, infarction size was also increased by T0070907 in the absence of PPAR‐γ agonist, suggesting that endogenous PPAR‐γ ligands may mitigate the effects of cerebral ischemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reversible middle cerebral artery occlusion without craniectomy in rats.
Longa, E. Z., Weinstein, P. R., Carlson, S., & Cummins, R. (1989) · Stroke · doi:10.1161/01.str.20.1.84 · Cited by 7,463 · cited 1×
“MCAO was performed as previously described by Longa and modified by Kawamura (Longa et al., 1989; Kawamura et al., 1991).”
MethodThe peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525
The mechanisms of action of PPARs
Berger, J., & Moller, D. E. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.104018 · Cited by 2,659
The PPARs: From Orphan Receptors to Drug Discovery
Willson, T. M., Brown, P. J., Sternbach, D. D., & Henke, B. R. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990554g · Cited by 1,816 · cited 3×
“Lipoprotein lipase (LPL) plays an important role in lipid metabolism; its promoter contains a PPRE and expression is increased by PPARc activation (Willson et al., 2000).”
BackgroundInfluentialChawla, A., Barak, Y., Nagy, L., Liao, D., Tontonoz, P., & Evans, R. M. (2001) · Nature Medicine · doi:10.1038/83336 · Cited by 1,069
Estrogen Actions Throughout the Brain
McEwen, B. (2002) · Recent Progress in Hormone Research · doi:10.1210/rp.57.1.357 · Cited by 915
Tugwood, J. D., Issemann, I., Anderson, R. G., Bundell, K. R., McPheat, W. L., & Green, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05072.x · Cited by 895 · cited 1×
“CTC-3¢ as previously described (Tugwood et al., 1992; Zhao et al., 2006).”
Heneka, M. T., Sastre, M., Dumitrescu-Ozimek, L., Hanke, A., Dewachter, I., Kuiperi, C., O'Banion, K., Klockgether, T., Van Leuven, F., & Landreth, G. E. (2005) · Brain · doi:10.1093/brain/awh452 · Cited by 565
Self-citationCombs, C. K., Johnson, D. E., Karlo, J. C., Cannady, S. B., & Landreth, G. E. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-02-00558.2000 · Cited by 483
Self-citationLee, G., Elwood, F., McNally, J., Weiszmann, J., Lindstrom, M., Amaral, K., Nakamura, M., Miao, S., Cao, P., Learned, R. M., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200743200 · Cited by 319 · cited 7×
“The concentration of T0070907 is three times the concentration at which 50% inhibition of [3H] rosiglitazone binding occurs (Lee et al., 2002).”
BackgroundMethodInfluentialYue, T.-L., Chen, J., Bao, W., Narayanan, P. K., Bril, A., Jiang, W., Lysko, P. G., Gu, J.-L., Boyce, R., Zimmerman, D. M., et al. (2001) · Circulation · doi:10.1161/hc4601.099403 · Cited by 295 · cited 1×
“Treatment with a variety of PPARc agonists reduces infarction size following myocardial ischemia (Wayman et al., 2002; Yue et al., 2002) and is also beneficial in pulmonary and renal ischemia (Ito et al., 2003; Sivarajah et al., 2003).”
BackgroundS., P. A. (2006) · doi:10.4049/jimmunol.176.7.4385 · Cited by 80
Localization of lipoprotein lipase mRNA in selected rat tissues
Goldberg, I. J., Soprano, D. R., Wyatt, M. L., Vanni, T. M., Kirchgessner, T. G., & Schotz, M. C. (1989) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38241-9 · Cited by 77
Cited by
Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists
Kapadia, R. (2008) · Frontiers in Bioscience · doi:10.2741/2802 · Cited by 433
Microglial Activation in Stroke: Therapeutic Targets
Yenari, M. A., Kauppinen, T. M., & Swanson, R. A. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.07.005 · Cited by 389
Roles of Peroxisome Proliferator-Activated Receptor Gamma on Brain and Peripheral Inflammation
Villapol, S. (2018) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-017-0554-5 · Cited by 369
HENEKA, M., & LANDRETH, G. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.04.016 · Cited by 317
Self-citationStress as a neuroinflammatory condition in brain: Damaging and protective mechanisms
García-Bueno, B., Caso, J. R., & Leza, J. C. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.04.001 · Cited by 280
Metadata
- Authors
- Victor, N. A., Wanderi, E. W., Gamboa, J., Zhao, X., Aronowski, J., Deininger, K., Lust, W. D., Landreth, G. E., & Sundararajan, S.
- Venue
- European Journal of Neuroscience
- Publisher
- Wiley
- Published
- 2006-09
- Volume
- 24
- Issue
- 6
- Pages
- 1653-1663
- ISSN
- 0953-816X (ISSN-L)
- 1460-9568
- OpenAlex
- W2156371985
- Cited by
- 142
- References
- 13
- FWCI
- 4.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.